After two years of postponement, the Thai Food and Drug Administration (FDA) has announced the implementation of ASEAN Harmonization on Pharmaceutical Registration effective January 1, 2009. This represents a significant change in the Thai FDA’s history of the registration of pharmaceutical products. This article provides an overview of the expected impact of the ASEAN Harmonization rules on both local manufacturers and multinational companies.